Classification of glioma based on prognostic alternative splicing

BMC Medical Genomics

Zhonglu Ren¹  Songtao Qi²  Kaishu Li²  Yuping Peng²  Xiran Wang²  Yawei Liu²  Yaomin Li²  Guanglong Huang² 

[1] College of Medical Information Engineering, Guangdong Pharmaceutical University;Department of Neurosurgery, Nanfang Hospital, Southern Medical University;

关键词: Glioma;    Glioblastoma;    Alternative splicing;    Prognosis;    Classification;   

DOI  :  10.1186/s12920-019-0603-7

来源: DOAJ

【 摘 要 】

Abstract Background Previously developed classifications of glioma have provided enormous advantages for the diagnosis and treatment of glioma. Although the role of alternative splicing (AS) in cancer, especially in glioma, has been validated, a comprehensive analysis of AS in glioma has not yet been conducted. In this study, we aimed at classifying glioma based on prognostic AS. Methods Using the TCGA glioblastoma (GBM) and low-grade glioma (LGG) datasets, we analyzed prognostic splicing events. Consensus clustering analysis was conducted to classified glioma samples and correlation analysis was conducted to characterize regulatory network of splicing factors and splicing events. Results We analyzed prognostic splicing events and proposed novel splicing classifications across pan-glioma samples (labeled pST1–7) and across GBM samples (labeled ST1–3). Distinct splicing profiles between GBM and LGG were observed, and the primary discriminator for the pan-glioma splicing classification was tumor grade. Subtype-specific splicing events were identified; one example is AS of zinc finger proteins, which is involved in glioma prognosis. Furthermore, correlation analysis of splicing factors and splicing events identified SNRPB and CELF2 as hub splicing factors that upregulated and downregulated oncogenic AS, respectively. Conclusion A comprehensive analysis of AS in glioma was conducted in this study, shedding new light on glioma heterogeneity and providing new insights into glioma diagnosis and treatment.

【 授权许可】

Unknown